FATALITY RESULTING FROM METHYLPHENIDATE OVERDOSE

被引:42
作者
LEVINE, B [1 ]
CAPLAN, YH [1 ]
KAUFFMAN, G [1 ]
机构
[1] OFF CHIEF MED EXAMINER,111 PENN ST,BALTIMORE,MD
关键词
D O I
10.1093/jat/10.5.209
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
引用
收藏
页码:209 / 210
页数:2
相关论文
共 11 条
[1]  
BARTLETT M F, 1972, Federation Proceedings, V31, P537
[2]  
CORSER G, 1975, ANAESTHESIA, V40, P51
[3]  
DAYTON P G, 1970, Federation Proceedings, V29, P345
[4]  
FARAJ BA, 1974, J PHARMACOL EXP THER, V191, P535
[5]  
GILMAN AG, 1980, PHARM BASIS THERAPEU, P580
[7]   CLINICAL CORRELATES OF METHYLPHENIDATE BLOOD-LEVELS [J].
GUALTIERI, CT ;
HICKS, RE ;
PATRICK, K ;
SCHROEDER, SR ;
BREESE, GR .
THERAPEUTIC DRUG MONITORING, 1984, 6 (04) :379-392
[8]   CLINICAL-STUDIES OF METHYLPHENIDATE SERUM LEVELS IN CHILDREN AND ADULTS [J].
GUALTIERI, CT ;
WARGIN, W ;
KANOY, R ;
PATRICK, K ;
SHEN, CD ;
YOUNGBLOOD, W ;
MUELLER, RA ;
BREESE, GR .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1982, 21 (01) :19-26
[9]   DISTRIBUTION AND ELIMINATION OF METHYLPHENIDATE-C-14 [J].
SHEPPARD, H ;
TSIEN, WH ;
RODEGKER, W ;
PLUMMER, AJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1960, 2 (04) :353-362
[10]  
WARGIN W, 1983, J PHARMACOL EXP THER, V226, P382